The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A_1c During the Treatment of Giant Cell Arteritis

Abstract

Tocilizumab treatment was associated with a substantial reduction in HbA_1c level, independent of glucocorticoid exposure, which may be achieved through a combination of glycemic and nonglycemic effects.